U.S. Clinical Trials Market Benefits from Growing Demand for Regenerative Medicine Solutions
According to Polaris Market Research, the U.S. cell and gene therapy clinical trials market was valued at USD 5.36 billion in 2024 and is projected to grow at a CAGR of 15.3% from 2025 to 2034, reflecting strong momentum in advanced therapy development. This growth is primarily driven by the rising demand for transformative treatments for rare genetic disorders and chronic diseases, where...
0 التعليقات 0 المشاركات 40 مشاهدة 0 معاينة
إعلان مُمول
Myliveroom — Live Events & Online Communities https://myliveroom.com